Hudson Bay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Hudson Bay Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.26M	Buy	+56,540	New	+$3.25M	0.01%	692
2025 Q4	–	Sell	-74,101	Closed	-$3.34M	–	1220
2025 Q3	$3.34M	Buy	74,101 +52,309	+240%	+$2.44M	0.01%	651
2025 Q2	$1.01M	Buy	21,792 +14,678	+206%	+$721K	﹤0.01%	959
2025 Q1	$434K	Buy	+7,114	New	+$415K	﹤0.01%	1044
2022 Q1	–	Sell	-45,000	Closed	-$2.81M	–	1203
2021 Q4	$2.81M	Sell	45,000 -20,000	-31%	-$1.17M	0.03%	577
2021 Q3	$3.85M	Buy	+65,000	New	+$4.28M	0.05%	446
2019 Q2	–	Sell	-60,500	Closed	-$2.89M	–	448
2019 Q1	$2.89M	Buy	60,500 +13,100	+28%	+$653K	0.04%	392
2018 Q4	$2.46M	Buy	+47,400	New	+$2.55M	0.03%	460
2018 Q2	–	Sell	-16,000	Closed	-$1.01M	–	786
2018 Q1	$1.01M	Sell	16,000 -34,000	-68%	-$2.19M	0.02%	572
2017 Q4	$3.06M	Buy	50,000 +1,504	+3%	+$94.1K	0.07%	247
2017 Q3	$3.09M	Buy	48,496 +13,996	+41%	+$817K	0.08%	202
2017 Q2	$1.92M	Sell	34,500 -288,922	-89%	-$15.7M	0.04%	345
2017 Q1	$17.6M	Buy	323,422 +285,536	+754%	+$15.7M	0.24%	86
2016 Q4	$2.21M	Sell	37,886 -230,939	-86%	-$12.6M	0.05%	328
2016 Q3	$14.5M	Buy	+268,825	New	+$17.3M	0.35%	52

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hudson Bay Capital Management's BMY Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 56,540 shares worth $3.26M. The stake represents 0.01% of the portfolio and ranks #692 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in BMY as recently as Q3 2025.

Hudson Bay Capital Management first reported a position in BMY in Q3 2016 and has held it in 15 quarters since. The position peaked at $17.6M in Q1 2017. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hudson Bay Capital Management held 56,540 shares of Bristol-Myers Squibb worth $3.26M as of Q2 2026.
Bristol-Myers Squibb was a new Hudson Bay Capital Management position in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #692 holding.
Hudson Bay Capital Management first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 15 quarters since.
Hudson Bay Capital Management's Bristol-Myers Squibb position peaked at $17.6M in Q1 2017.
2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.